← Back to Patent Explorer
US4600531A Expired / Lapsed US ⏱️ 0.0 years remaining

Production of alpha-alpha cross-linked hemoglobins in high yield

Assignee: University of Iowa Research Foundation
•
Filing: 1985-03-18
•
Granted: 1986-07-15
•
Expires: 2005-03-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A high yield method of production of a cross-linked hemoglobin derivative suitable for use as a blood substitute and plasma expander which is cross-linked between Lys 99 Alpha1 and Lys 99 Alpha2 in high percentage by adding the cross-linker in the presence of an added polyanion which blocks competing reactions at other sites of the protein.

Inventors

  • 👤 Joseph A. Walder

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 05:54
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/795; C07K14/805; A; A61; A61P; A61P7/00; A61P7/08; A61K; A61K38/00

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 77 words
A method of producing in commercially significant yields, a modified hemoglobin which is capable of functioning as a blood substitute and blood plasma expander, comprising: isolating unmodified hemoglobin or preparing a crude red cell lysate; deoxygenating said hemoglobin; cross-linking said deoxygenated hemoglobin intramolecularly between Lys 99 Alpha 1 and Lys 99 Alpha 2 in the presence of an added polyanion selected from the group consisting of 2,3-diphosphoglycerate, inositol hexaphosphate, inositol hexasulfate; and purifying said alpha-alpha cross-linked hemoglobin.
Claim 2
Independent Claim 77 words
A method of producing in commercially significant yields, a modified hemoglobin which is capable of functioning as a blood substitute and blood plasma expander, comprising: isolating unmodified hemoglobin or preparing a crude red cell lysate; deoxygenating said hemoglobin; cross-linking said deoxygenated hemoglobin intramolecularly between Lys 99 Alpha 1 and Lys 99 Alpha 2 in the presence of an added polyanion selected from the group consisting of 2,3-diphosphoglycerate, inositol hexaphosphate, inositol hexasulfate; and purifying said alpha-alpha cross-linked hemoglobin.
Claim 3
Dependent Claim 10 words
The method of claim 1 wherein said polyanion is 2,3-diphosphoglycerate.
Claim 4
Dependent Claim 11 words
The method of claim 1 wherein said polyanion is inositol hexasulfate.
Claim 5
Dependent Claim 11 words
The method of claim 1 wherein said polyanion is inositol hexaphosphate.
Claim 6
Dependent Claim 22 words
The method of claim 1 wherein the reaction is conducted at a temperature of from about 0° C. to about 40° C.
Claim 7
Dependent Claim 22 words
The method of claim 5 wherein the reaction is conducted at a temperature of from about 35° C. to about 40° C.
Claim 8
Dependent Claim 17 words
The method of claim 6 wherein the reaction is conducted at a temperature of about 37° C.
Claim 9
Dependent Claim 27 words
The method of claim 1 wherein the cross-linking between Lys 99 Alpha 1 and Lys 99 Alpha 2 is with a cross-linking agent which is amino group-specific.
Claim 10
Dependent Claim 15 words
The method of claim 8 wherein said cross-linking agent is a phenyl ester cross-linking agent.
Claim 11
Dependent Claim 11 words
The method of claim 9 wherein said cross-linking agent is bis(3,5-dibromosalicyl)fumarate.
Claim 12
Dependent Claim 25 words
The method of claim 8 wherein the amount of cross-linking agent employed is up to a three fold molar excess of the amount of hemoglobin.
Claim 13
Dependent Claim 26 words
The method of claim 11 wherein the amount of cross-linking agent is from about 1.3 times to about 2.0 times the molar amount of said hemoglobin.
Claim 14
Dependent Claim 31 words
The method of claim 11 wherein the amount of the polyanion is from an amount equimolar to the amount of hemoglobin up to a twenty fold excess of the equimolar amount.
Claim 15
Dependent Claim 25 words
The method of claim 13 wherein the amount of the polyanion is from about 5 to about 10 times the molar amount of said hemoglobin.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-07-14 1990-01-13 1990-07-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-07-14 1994-01-13 1994-07-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-07-14 1998-01-13 1998-07-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag